Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Rating)’s stock price gapped up prior to trading on Wednesday following insider buying activity. The stock had previously closed at $12.14, but opened at $12.76. Cullinan Oncology shares last traded at $12.54, with a volume of 4,066 shares trading hands. Specifically, major shareholder Bvf Partners L. P/Il purchased 276,000 […]
Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Rating) gapped down prior to trading on Friday . The stock had previously closed at $12.12, but opened at $11.86. Cullinan Oncology shares last traded at $11.97, with a volume of 101 shares. A number of equities analysts have recently weighed in on CGEM shares. HC Wainwright cut their […]
Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Rating) – Investment analysts at SVB Leerink upped their FY2026 EPS estimates for Cullinan Oncology in a research note issued to investors on Thursday, March 17th. SVB Leerink analyst A. Berens now expects that the company will post earnings per share of $2.82 for the year, up from their […]
Cullinan Oncology (NASDAQ:CGEM – Get Rating) issued its quarterly earnings data on Thursday. The company reported ($0.74) earnings per share for the quarter, missing the consensus estimate of ($0.50) by ($0.24), MarketWatch Earnings reports. CGEM stock traded up $0.52 during midday trading on Friday, hitting $13.33. The stock had a trading volume of 726,025 shares, […]